X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardio-oncology (475) 475
cardiotoxicity (253) 253
index medicus (231) 231
cancer (187) 187
cardiac & cardiovascular systems (178) 178
chemotherapy (144) 144
humans (142) 142
cardiology (101) 101
oncology (95) 95
heart failure (94) 94
risk factors (88) 88
medicine & public health (78) 78
care and treatment (76) 76
heart-failure (75) 75
breast-cancer (72) 72
echocardiography (68) 68
cardiovascular (60) 60
antineoplastic agents - adverse effects (59) 59
trastuzumab (57) 57
anthracyclines (53) 53
female (51) 51
heart (51) 51
anthracycline (49) 49
cardiovascular diseases (49) 49
therapy (49) 49
breast cancer (48) 48
doxorubicin (48) 48
cardiovascular disease (46) 46
hypertension (46) 46
management (44) 44
cancer therapies (43) 43
health aspects (43) 43
heart diseases (43) 43
prevention (41) 41
cardiomyopathy (40) 40
neoplasms - drug therapy (40) 40
patients (39) 39
research (38) 38
diagnosis (37) 37
american society (36) 36
biomarkers (33) 33
complications and side effects (33) 33
middle aged (33) 33
mortality (33) 33
cardiac patients (31) 31
pharmacology & pharmacy (31) 31
toxicity (31) 31
usage (31) 31
article (30) 30
male (30) 30
analysis (29) 29
cancer patients (29) 29
review (29) 29
tyrosine kinase inhibitors (29) 29
animals (28) 28
cardiac dysfunction (28) 28
cardiovascular toxicity (27) 27
european association (27) 27
internal medicine (27) 27
left-ventricular dysfunction (26) 26
aged (25) 25
drug therapy (25) 25
radiotherapy (25) 25
risk (25) 25
cardio‐oncology (24) 24
antineoplastic agents - therapeutic use (22) 22
congestive-heart-failure (22) 22
induced cardiotoxicity (22) 22
abridged index medicus (21) 21
anthracyclines - adverse effects (21) 21
cardiovascular diseases - chemically induced (21) 21
radiology, nuclear medicine & medical imaging (21) 21
troponin-i (21) 21
adult (20) 20
radiation (20) 20
survivors (20) 20
breast neoplasms - drug therapy (19) 19
childhood-cancer (18) 18
dysfunction (18) 18
expert consensus (18) 18
magnetic resonance imaging (18) 18
medical colleges (18) 18
medicine (18) 18
neoplasms - therapy (18) 18
oncology, experimental (18) 18
cancer therapy (17) 17
hematology (17) 17
survival (17) 17
troponin (17) 17
ventricle (17) 17
acute myocardial-infarction (16) 16
cardiac toxicity (16) 16
diseases of the circulatory system (16) 16
neoplasms - complications (16) 16
prognosis (16) 16
risk-factors (16) 16
tyrosine (16) 16
acute lymphoblastic-leukemia (15) 15
anthracycline-induced cardiotoxicity (15) 15
antineoplastic agents (15) 15
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (470) 470
German (5) 5
Spanish (5) 5
French (4) 4
Portuguese (3) 3
Russian (3) 3
Chinese (2) 2
Italian (2) 2
Hungarian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 06/2019, Volume 40, Issue 22, pp. 1756 - 1763
Abstract Aims Anticancer therapies have extended the lives of millions of patients with malignancies, but for some this benefit is tempered by adverse... 
Cardio-oncology | Services | Management | Cancer
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2018, Volume 72, Issue 2, pp. 228 - 232
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 02/2019, Volume 73, Issue 7, pp. 792 - 794
Journal Article
European Journal of Medical Research, ISSN 0949-2321, 01/2019, Volume 24, Issue 1, p. 1
Journal Article
Trends in cardiovascular medicine, ISSN 1050-1738, 02/2019
Journal Article
Revista de la Federacion Argentina de Cardiologia, ISSN 0326-646X, 07/2018, Volume 47, Issue 3, pp. 113 - 119
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2019, Volume 74, Issue 4, pp. 567 - 577
A novel, common, and potent cardiovascular risk factor has recently emerged: clonal hematopoiesis of indeterminate potential (CHIP). CHIP arises from somatic... 
leukemia | cancer | cardio-oncology | cardiovascular risk | leukocyte
Journal Article
International Heart Journal, ISSN 1349-2365, 2018
Aortic stenosis (AS) is a life-threatening comorbidity of cancer patients. Aortic valve replacement (AVR) should be considered for some cancer patients, but... 
Cancer stage | Prognosis | Cardio-oncology
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 05/2019, Volume 19, Issue 5, pp. 359 - 374
Introduction: Recent breakthroughs in cancer treatment has improved the prospects and life expectancy of cancer patients. Therefore, risk of cardiotoxicity... 
Cardiotoxicity | cardio-oncology | troponin | biomarkers | prevention
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2019, Volume 73, Issue 11, pp. 1336 - 1349
Patients with active cancer are at an increased risk of arterial and venous thromboembolism (VTE) and bleeding events. Historically, in patients with cancer,... 
atrial fibrillation | cancer | bleeding | cardio-oncology | venous thromboembolism | anticoagulation
Journal Article
European Heart Journal, ISSN 0195-668X, 09/2016, Volume 37, Issue 36, pp. 2768 - 2801
Journal Article
British Journal of Cardiology, ISSN 0969-6113, 01/2018, Volume 25, Issue 1
Journal Article
International Heart Journal, ISSN 1349-2365, 2018, Volume 59, Issue 4, pp. 750 - 758
Aortic stenosis (AS) is a life-threatening comorbidity of cancer patients. Aortic valve replacement (AVR) should be considered for some cancer patients, but... 
Cancer stage | Cardio-oncology | Prognosis
Journal Article
Revista Colombiana de Cardiologia, ISSN 0120-5633, 01/2018, Volume 25, pp. 144 - 153
Thanks to the advances in cancer treatment which have increased women's survival rates, the cardiovascular effects of this oncological therapy are seen more... 
Women | Cardio-oncology | Cardiotoxicity | Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.